Russell Frank Company’s Amedisys AMED Stock Holding History

Russell Frank Company’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$13M	Buy	268,196 +90,093	+51%	+$3.48M	0.02%	801
2015 Q4	$7.21M	Buy	178,103 +95,777	+116%	+$3.83M	0.01%	1064
2015 Q3	$3.13M	Buy	82,326 +22,359	+37%	+$943K	0.01%	1582
2015 Q2	$2.38M	Buy	59,967 +28,862	+93%	+$899K	﹤0.01%	1872
2015 Q1	$833K	Sell	31,105 -21,129	-40%	-$596K	﹤0.01%	2230
2014 Q4	$1.53M	Sell	52,234 -11,748	-18%	-$290K	﹤0.01%	1931
2014 Q3	$1.29M	Buy	+63,982	New	+$1.23M	﹤0.01%	1949
2013 Q4	–	Sell	-22,210	Closed	-$382K	–	2796
2013 Q3	$382K	Buy	22,210 +8,894	+67%	+$132K	﹤0.01%	2584
2013 Q2	$175K	Buy	+13,316	New	+$153K	﹤0.01%	2608

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's AMED Position: Q1 2016 in Review

Russell Frank Company increased its Amedisys (AMED) stake by 51% in Q1 2016, buying an estimated $3.48M and bringing the position to 268,196 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #801.

Russell Frank Company first reported a position in AMED in Q2 2013 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold AMED as of Q1 2016.

Russell Frank Company held 268,196 shares of Amedisys worth $13M as of Q1 2016.
Russell Frank Company bought 90,093 Amedisys shares in Q1 2016, an estimated $3.48M.
Amedisys made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #801 holding.
Russell Frank Company first reported a position in Amedisys in Q2 2013 and has held it in 9 quarters since.
169 funds tracked by Wall St. Rank held Amedisys as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.